The IRAK4 kinase inhibitor PF‐06650833 blocks inflammation in preclinical models of rheumatologic disease and in humans enrolled in a randomized clinical trial
Keyword(s):
2013 ◽
Vol 68
(4)
◽
pp. AB199
2002 ◽
Vol 89
(2)
◽
pp. 154-157
◽
2001 ◽
Vol 120
(5)
◽
pp. A453-A453
◽
Keyword(s):
Keyword(s):
Keyword(s):